MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.

Meltzer, Eli O; LaForce, Craig; Ratner, Paul; Price, David; Ginsberg, David; Carr, Warner

Meltzer, Eli O; LaForce, Craig; Ratner, Paul; Price, David; Ginsberg, David; Carr, Warner.

Affiliation

Meltzer EO; Allergy and Asthma Medical Group and Research Center, San Diego, California 92123, USA. EOMELTZER@aol.com

Allergy Asthma Proc ; 33(4): 324-32, 2012.

Article in En | MEDLINE | ID: mdl-22856633

Subject(s)

Androstadienes/administration & dosage; Androstadienes/adverse effects; Anti-Allergic Agents/administration & dosage; Anti-Allergic Agents/adverse effects; Phthalazines/administration & dosage; Phthalazines/adverse effects; Rhinitis, Allergic, Seasonal/drug therapy; Administration, Intranasal; Adolescent; Adult; Aged; Androstadienes/therapeutic use; Anti-Allergic Agents/therapeutic use; Child; Double-Blind Method; Drug Combinations; Female; Fluticasone; Humans; Male; Middle Aged; Phthalazines/therapeutic use; Quality of Life; Rhinitis, Allergic, Seasonal/physiopathology; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Rhinitis, Allergic, Seasonal / Anti-Allergic Agents / Androstadienes Type of study: Clinical_trials Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Allergy Asthma Proc Journal subject: ALERGIA E IMUNOLOGIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google